39.43
price down icon1.08%   -0.43
after-market After Hours: 38.85 -0.58 -1.47%
loading
Tg Therapeutics Inc stock is traded at $39.43, with a volume of 3.78M. It is down -1.08% in the last 24 hours and up +31.04% over the past month.
See More
Previous Close:
$39.86
Open:
$38.32
24h Volume:
3.78M
Relative Volume:
1.57
Market Cap:
$4.54B
Revenue:
$264.79M
Net Income/Loss:
$-14.36M
P/E Ratio:
-358.45
EPS:
-0.11
Net Cash Flow:
$-28.11M
1W Performance:
-7.46%
1M Performance:
+31.04%
6M Performance:
+68.58%
1Y Performance:
+159.24%
1-Day Range:
Value
$36.41
$39.61
1-Week Range:
Value
$36.41
$42.92
52-Week Range:
Value
$12.93
$43.32

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Name
Tg Therapeutics Inc
Name
Phone
(212) 554-4484
Name
Address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Employee
0
Name
Twitter
@TGTherapeutics
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
TGTX's Discussions on Twitter

Compare TGTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TGTX
Tg Therapeutics Inc
39.43 4.54B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-29-24 Initiated TD Cowen Buy
Aug-02-23 Upgrade Goldman Sell → Neutral
Jun-26-23 Resumed Jefferies Buy
May-20-22 Initiated BofA Securities Underperform
Feb-23-22 Reiterated B. Riley Securities Buy
Nov-15-21 Downgrade Goldman Neutral → Sell
Apr-20-21 Initiated Goldman Neutral
Apr-19-21 Reiterated H.C. Wainwright Buy
Sep-01-20 Initiated JP Morgan Overweight
Aug-11-20 Reiterated H.C. Wainwright Buy
Jun-05-20 Initiated Evercore ISI Outperform
Jan-17-20 Reiterated H.C. Wainwright Buy
Nov-27-19 Resumed B. Riley FBR Buy
Feb-06-19 Resumed Jefferies Buy
Sep-25-18 Downgrade Raymond James Strong Buy → Outperform
Mar-09-18 Reiterated B. Riley FBR, Inc. Buy
Dec-01-17 Resumed B. Riley FBR, Inc. Buy
Nov-14-17 Resumed H.C. Wainwright Buy
Apr-25-17 Initiated Jefferies Buy
Mar-06-17 Reiterated FBR & Co. Outperform
Oct-06-16 Resumed Brean Capital Buy
May-27-16 Initiated SunTrust Buy
Dec-01-15 Initiated FBR Capital Outperform
Sep-09-15 Initiated Raymond James Strong Buy
Aug-12-15 Resumed H.C. Wainwright Buy
Jun-19-15 Reiterated Brean Capital Buy
Dec-11-14 Reiterated ROTH Capital Buy
Dec-10-14 Reiterated ROTH Capital Buy
View All

Tg Therapeutics Inc Stock (TGTX) Latest News

pulisher
Mar 30, 2025

Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%? - Yahoo Finance

Mar 30, 2025
pulisher
Mar 25, 2025

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Based On Its ROE, Is TG Therapeutics, Inc. (NASDAQ:TGTX) A High Quality Stock? - simplywall.st

Mar 25, 2025
pulisher
Mar 23, 2025

(TGTX) Investment Analysis and Advice - Stock Traders Daily

Mar 23, 2025
pulisher
Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

TG Therapeutics (TGTX) technical analysisTG Therapeutics (NASDAQ:TGTX) - Benzinga

Mar 21, 2025
pulisher
Mar 19, 2025

TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts - Yahoo Finance

Mar 19, 2025
pulisher
Mar 17, 2025

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies and Companies by DelveInsight - The Globe and Mail

Mar 17, 2025
pulisher
Mar 15, 2025

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Mar 15, 2025
pulisher
Mar 15, 2025

TG Therapeutics stock soars to 52-week high of $40.32 By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 14, 2025

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials (NASDAQ:TGTX) - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

TG Therapeutics stock soars to 52-week high of $40.32 - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

TG Therapeutics Stock (TGTX): Advancing MS Treatment - Value The Markets

Mar 14, 2025
pulisher
Mar 14, 2025

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025? - Insider Monkey

Mar 14, 2025
pulisher
Mar 13, 2025

(TGTX) Technical Data - Stock Traders Daily

Mar 13, 2025
pulisher
Mar 12, 2025

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter (NASDAQ:TGTX) - Seeking Alpha

Mar 12, 2025
pulisher
Mar 12, 2025

10 Best Performing Growth Stocks in 2025 - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Proficio Capital Partners LLC Buys Shares of 10,174 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

TG Therapeutics call volume above normal and directionally bullish - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Smartleaf Asset Management LLC Has $60,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround - Yahoo Finance

Mar 09, 2025
pulisher
Mar 09, 2025

Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? - Benzinga

Mar 09, 2025
pulisher
Mar 09, 2025

Bank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Why TG Therapeutics Stock Was Soaring This Week - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

TGTX Surges on Strong Q4 Results and Briumvi Success - GuruFocus.com

Mar 07, 2025
pulisher
Mar 07, 2025

Why TG Therapeutics Shares Are Soaring Now - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

This Biotech Stock Hits Buy Point After Earnings Burst - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

HC Wainwright Reaffirms “Buy” Rating for TG Therapeutics (NASDAQ:TGTX) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

TG Therapeutics FY2025 EPS Estimate Boosted by HC Wainwright - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Why TG Therapeutics, Inc. (TGTX) Surged On Monday? - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Holdings Decreased by Private Advisor Group LLC - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics (NASDAQ:TGTX) Upgraded by StockNews.com to Hold Rating - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics (NASDAQ:TGTX) Shares Up 5.2% After Earnings Beat - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 04, 2025

TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics stock soars to 52-week high of $36.89 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics stock soars to 52-week high of $36.89 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

B. Riley Raises Price Target on TG Therapeutics to $53 From $38, Keeps Buy Rating -March 04, 2025 at 08:05 am EST - Marketscreener.com

Mar 04, 2025

Tg Therapeutics Inc Stock (TGTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):